Ophthalmic Case Studies and Novel Approach

Track:25-Ophthalmic Case Studies and Novel Approach
In a small randomized controlled trial, production of aqueous tears and secretion of goblet cells increased following application of the Oculeve Intranasal Lacrimal Neurostimulator (Allergan).1 This handheld device works by delivering electrical stimulation to the anterior ethmoidal branch of the trigeminal nerve in the nasal cavities. It potentially offers a new mechanism for treating dry eye disease—now largely managed with artificial tears and anti-inflammatory agents.


    Related Conference of Ophthalmic Case Studies and Novel Approach

    December 15-16, 2022

    3rd World Congress on Ophthalmology & Optometry

    London, UK
    February 02-03, 2023

    6th International Eye and Vision Congress

    Barcelona, Spain
    February 20-21, 2023

    4th International Conference on Ear Nose & Throat

    Singapore City, Singapore
    April 20-21, 2023

    8th International Conference on Eye and Vision

    Paris, France
    May 17-18, 2023

    23rd Global Ophthalmologists Annual Meeting

    Prague, Czech Republic
    May 24-25, 2023

    3rd International Conference on Optics & Photonics

    Montreal, Canada
    May 31-01, 2023

    9th Global Ophthalmology Meeting

    Rome, Italy
    July 26-27, 2023

    17th International Conference on Hepatology

    Singapore City, Singapore
    July 31-01, 2023

    37th European Ophthalmology Congress

    Vancouver, Canada
    August 28-29, 2023

    22nd Asia Pacific Ophthalmologists Annual Meeting

    Tokyo, Japan
    September 18-19, 2023

    33rd International Congress on Vision Science and Eye

    Rome, Italy
    October 09-10, 2023

    4th International Conference on Optometry

    Prague, Czech Republic
    November 01-02, 2023

    19th International Conference on Metabolomics

    Rome, Italy

    Ophthalmic Case Studies and Novel Approach Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in